Amlodipine

Amlodipine is a calcium channel blocker approved in 1987 that lowers blood pressure and treats some forms of angina. Its long half-life of about 30 to 50 hours is the key practical fact because it allows once-daily dosing for many patients. Brand names include Norvasc and, in India, brands such as Amlong. It belongs to the dihydropyridine class and is commonly used for hypertension, chronic stable angina, and vasospastic angina. In routine care, it may be prescribed alone or combined with other blood pressure medicines such as an angiotensin receptor blocker, ACE inhibitor, or thiazide-type diuretic.

What it is

Amlodipine is an oral prescription medicine that relaxes blood vessels. It is one of the most widely used antihypertensive drugs because it works over 24 hours, is generally well tolerated, and does not usually require frequent lab monitoring.

Common approved uses include:

Use	What it means
Hypertension	Lowers high blood pressure to reduce cardiovascular risk
Chronic stable angina	Helps prevent chest pain triggered by exertion
Vasospastic angina	Helps prevent coronary artery spasm
Coronary artery disease in selected patients	May improve symptoms and reduce angina-related burden

For hypertension, amlodipine is often considered a first-line option. This fits common practice in many countries, including India, where long-acting blood pressure medicines are widely used because adherence is better with once-daily treatment. The exact tablet strength and whether it is used alone or in a fixed-dose combination depend on the clinician's plan.

How it works

Amlodipine blocks L-type calcium channels, mainly in vascular smooth muscle. Less calcium enters these cells, so the muscle in artery walls relaxes. This widens arteries, lowers peripheral vascular resistance, and reduces blood pressure.

Its anti-angina effect comes from two related actions:

1. It lowers afterload, so the heart does not have to pump against as much resistance.
2. It can improve coronary blood flow, especially in vasospastic angina where artery spasm is part of the problem.

Amlodipine is different from non-dihydropyridine calcium channel blockers such as verapamil and diltiazem. It acts more on blood vessels than on the heart's conduction system, so it is not mainly used to slow heart rate. Because its half-life is long, blood pressure control is smoother across the day and night than with shorter-acting agents.

Evidence and uses

Amlodipine has strong evidence for lowering blood pressure and improving angina symptoms. Reviews of hypertension management describe it as effective across a broad range of patients, including older adults, and note that it can reduce blood pressure variability as well as average blood pressure.

A practical point is that dose increases can produce additional blood pressure lowering. In one pooled analysis, titrating amlodipine from 5 mg to 10 mg daily led to statistically significant further reductions in both systolic and diastolic blood pressure. That does not mean every patient should use the higher dose, because side effects such as ankle swelling can become more common as the dose rises.

Amlodipine is often chosen when a patient has:

• Hypertension needing once-daily treatment
• Isolated systolic hypertension, especially in older adults
• Angina along with hypertension
• Need for combination therapy with another class

It does not treat every cause of chest pain, and it is not a substitute for emergency treatment of a heart attack. If chest pain is new, severe, or worsening, urgent medical evaluation is needed.

Safety and interactions

Amlodipine is generally well tolerated, but side effects are common enough that patients should know what to watch for.

Common side effects include:

Side effect	Notes
Peripheral edema	Ankle or foot swelling is one of the best-known adverse effects
Flushing	From blood vessel dilation
Headache	Often mild, sometimes improves with time
Dizziness	More likely when starting or increasing dose
Palpitations	Can occur from vasodilation-related reflex effects
Fatigue	Reported by some patients

Peripheral edema is especially important. It is usually due to fluid shifting from blood vessels into tissues rather than the body retaining total excess fluid, so adding a diuretic does not always fix it. In some patients, combining amlodipine with an ACE inhibitor or ARB may reduce this problem.

Serious adverse effects are less common but can include marked low blood pressure, worsening chest pain when starting therapy in rare cases, or allergic reactions. Pharmacovigilance studies also detect signals for less common events, but such studies cannot by themselves prove that the drug caused every reported event.

Important interaction points:

• Amlodipine is metabolized by CYP3A4, so strong inhibitors or inducers can change drug levels.
• Simvastatin exposure can increase when used with amlodipine; clinicians often limit simvastatin dose in this combination.
• Other blood pressure medicines can add to the blood pressure-lowering effect.
• Grapefruit interactions are less prominent than with some other calcium channel blockers, but patients should still ask a pharmacist if they use large amounts regularly.

People with severe aortic stenosis, very low blood pressure, advanced liver impairment, or certain heart conditions may need extra caution. Do not stop amlodipine on your own if it is being used for angina or blood pressure control. If side effects occur, talk to a clinician or pharmacist about adjustment rather than abruptly discontinuing it.

When to see a clinician

Contact a clinician promptly if you develop troublesome ankle swelling, fainting, severe dizziness, very low blood pressure readings, or chest pain that is new or getting worse. Seek urgent care for symptoms of a heart attack or stroke, such as crushing chest pain, shortness of breath, weakness on one side, or trouble speaking.

Routine follow-up matters because the goal is not just taking the tablet but reaching a safe blood pressure target. Home blood pressure monitoring can help show whether the medicine is working across the day. In India and elsewhere, validated upper-arm monitors are preferred over unvalidated devices.

Limitations and open questions

Amlodipine is effective, but it is not ideal for every patient. Some people stop it because of edema, flushing, or headache. It also does not address all contributors to cardiovascular risk, so treatment usually still includes lifestyle measures such as reducing excess sodium, maintaining a healthy weight, regular physical activity, and not smoking.

Evidence for blood pressure reduction and angina control is strong, but questions remain about the best combinations for specific patient groups and how to balance efficacy against dose-related edema. Real-world safety studies are useful for signal detection, yet they have limits because spontaneous reports can be incomplete and cannot establish causation on their own. The right dose and combination should be individualized by a clinician based on blood pressure readings, symptoms, age, kidney and liver function, and other medicines.